{"id":214803,"title":"Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca","sourceCode":"hc","sourceName":"Health Canada","language":"en","captureDate":"2025-04-18","captureTimestamp":"2025-04-18T18:51:30.566000+00:00","jobId":1,"originalUrl":"https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html?wbdisable=false","snippet":"Archived 34: Summary of NACI statement of March 11, 2022: Recommendations on the use of Medicago COVID-19 vaccine (Covifenz) - Canada.ca Skip to main content Skip to \"About government\" We have archived this page and will not be updating it. You can use it for research or…","rawSnapshotUrl":"/api/snapshots/raw/214803","browseUrl":"https://replay.healtharchive.ca/job-1/20250418185130/https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/recommendations-use-medicago-covid-19-vaccine/summary-march-11-2022.html?wbdisable=false#ha_snapshot=214803","mimeType":"text/html","statusCode":200}